Clinical Cancer Research Meeting Calendar Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caputo, R.
Right arrow Articles by Romano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caputo, R.
Right arrow Articles by Romano, M.
Clinical Cancer Research Vol. 9, 2015-2021, June 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Helicobacter pylori VacA Toxin Up-Regulates Vascular Endothelial Growth Factor Expression in MKN 28 Gastric Cells through an Epidermal Growth Factor Receptor-, Cyclooxygenase-2-dependent Mechanism1

Rosa Caputo2, Concetta Tuccillo2, Barbara A. Manzo, Raffaele Zarrilli, Giampaolo Tortora, Camillo Del Vecchio Blanco, Vittorio Ricci, Fortunato Ciardiello3 and Marco Romano3

Dipartimento di Internistica Clinica e Sperimentale-Cattedra di Gastroenterologia, Seconda Università di Napoli, Napoli [C. T., B. A. M., C. D. V. B., M. R.]; Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università Federico II, 80131 Napoli [R. C., G. T., F. C.]; Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università Federico II, Napoli [R. Z.]; and Istituto di Fisiologia Umana, Università di Pavia [V. R.], Italy

Purpose: Helicobacter pylori causes gastric damage and is involved in gastric carcinogenesis. Vascular endothelial growth factor (VEGF) plays a major role in gastric mucosa repair and is overexpressed in gastric cancer. We investigated: (a) whether H. pylori, and in particular H. pylori VacA toxin, affected VEGF expression in gastric epithelial cells in culture; and (b) the signal transduction pathway involved in any effect exerted by H. pylori.

Experimental Design: MKN-28 cells were incubated with uninoculated BCF (control) or with BCF obtained from VacA-producing wild-type H. pylori 60190 strain or from its isogenic mutant 60190:v1, specifically lacking vacA gene in the presence or absence of ZD 1839, a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, PD098059, a selective inhibitor of mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase, the kinase responsible for ERK phosphorylation, or SC-236, a selective inhibitor of cyclooxygenase (COX)-2 for 24–48 h.

Results: (a) Toxigenic H. pylori up-regulated VEGF mRNA and protein expression and caused a 2.5-fold increase in VEGF release compared with control, whereas nontoxigenic H. pylori did not; (b) H. pylori VacA toxin-induced up-regulation of VEGF was counteracted by selective inhibition of EGFR tyrosine kinase; (c) toxigenic H. pylori activated the ERK/MAP kinase cascade, and inhibition of MAP kinase activation counteracted H. pylori-induced VEGF up-regulation; (d) toxigenic H. pylori up-regulated COX-2 expression, and this effect was counteracted by blockade of EGFR tyrosine kinase; and (e) COX-2 selective inhibition counteracted H. pylori-induced up-regulation of VEGF.

Conclusion: (a) H. pylori up-regulates VEGF expression in gastric epithelial cells; and (b) this effect is specifically related to VacA toxin and seems to depend on the activation of an EGFR-, MAP kinase-, and COX-2-mediated pathway.




This article has been cited by other articles:


Home page
Anticancer ResHome page
T. TAHARA, T. ARISAWA, T. SHIBATA, M. NAKAMURA, H. YAMASHITA, D. YOSHIOKA, M. OKUBO, N. MARUYAMA, T. KAMANO, Y. KAMIYA, et al.
Effect of Polymorphisms in the 3'-Untranslated Region (3'-UTR) of VEGF Gene on Gastric Pre-malignant Condition
Anticancer Res, February 1, 2009; 29(2): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Basu, S. K. Pathak, G. Chatterjee, S. Pathak, J. Basu, and M. Kundu
Helicobacter pylori Protein HP0175 Transactivates Epidermal Growth Factor Receptor through TLR4 in Gastric Epithelial Cells
J. Biol. Chem., November 21, 2008; 283(47): 32369 - 32376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M.-R. Ki, H.-R. Lee, M.-J. Goo, I.-H. Hong, S.-H. Do, D.-H. Jeong, H.-J. Yang, D.-W. Yuan, J.-K. Park, and K.-S. Jeong
Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G635 - G647.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Hisatsune, E. Yamasaki, M. Nakayama, D. Shirasaka, H. Kurazono, Y. Katagata, H. Inoue, J. Han, J. Sap, K. Yahiro, et al.
Helicobacter pylori VacA Enhances Prostaglandin E2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 Cells
Infect. Immun., September 1, 2007; 75(9): 4472 - 4481.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Yeo, D-K Kim, S U Han, J E Lee, Y B Kim, Y K Cho, J H Kim, S W Cho, and K-B Hahm
Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis
Gut, January 1, 2006; 55(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Y. Shin, W. K.K. Wu, Y.-N. Ye, W. H.L. So, M. W.L. Koo, E. S.L. Liu, J.-C. Luo, and C.-H. Cho
Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2
Carcinogenesis, December 1, 2004; 25(12): 2487 - 2495.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. J. Chang, M. S. Wu, J. T. Lin, B. S. Sheu, T. Muta, H. Inoue, and C.-C. Chen
Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-{kappa}B Activation
Mol. Pharmacol., December 1, 2004; 66(6): 1465 - 1477.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. R. Preusch, A. J. Grau, F. Buggle, C. Lichy, J. Bartel, C. Black, and J. Rudi
Association Between Cerebral Ischemia and Cytotoxin-Associated Gene-A-Bearing Strains of Helicobacter pylori
Stroke, August 1, 2004; 35(8): 1800 - 1804.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. C. Yao, L. Wang, D. Wei, W. Gong, M. Hassan, T.-T. Wu, P. Mansfield, J. Ajani, and K. Xie
Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 4109 - 4117.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakayama, M. Kimura, A. Wada, K. Yahiro, K.-i. Ogushi, T. Niidome, A. Fujikawa, D. Shirasaka, N. Aoyama, H. Kurazono, et al.
Helicobacter pylori VacA Activates the p38/Activating Transcription Factor 2-mediated Signal Pathway in AZ-521 Cells
J. Biol. Chem., February 20, 2004; 279(8): 7024 - 7028.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.